Literature DB >> 1675688

Protracted withdrawal syndromes from benzodiazepines.

H Ashton1.   

Abstract

The benzodiazepine withdrawal syndrome is a complex phenomenon which presents serious difficulties in definition and measurement. It is particularly difficult to set out precise limits on its duration. Many withdrawal symptoms are a result of pharmacodynamic tolerance to benzodiazepines, some mechanisms for which are discussed. Such tolerance develops unevenly in different brain systems and may be slow to reverse. Withdrawal symptoms occurring in the first week after cessation of drug use tend to merge with more persistent symptoms that may last for many months. These prolonged symptoms do not necessarily constitute "true" pharmacological withdrawal symptoms, but are nevertheless related to long-term benzodiazepine use. Such symptoms can include anxiety, which may partly result from a learning deficit imposed by the drugs, and a variety of sensory and motor neurological symptoms. The protracted nature of some of these symptoms raises the possibility that benzodiazepines can give rise not only to slowly reversible functional changes in the central nervous system, but may also occasionally cause structural neuronal damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675688     DOI: 10.1016/0740-5472(91)90023-4

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  19 in total

Review 1.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

2.  Benzodiazepine tolerance, dependency, and withdrawal syndromes and interactions with fluoroquinolone antimicrobials.

Authors:  John Girvan McConnell
Journal:  Br J Gen Pract       Date:  2008-05       Impact factor: 5.386

3.  Preference for diazepam, but not buspirone, in moderate drinkers.

Authors:  S M Evans; R R Griffiths; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

4.  Denying renal transplantation to an adolescent medical cannabis user: An ethical case study.

Authors:  Jennie E Ryan; Maia Noeder; Christine Burke; Samuel C Stubblefield; Salwa Sulieman; Elissa G Miller
Journal:  Pediatr Transplant       Date:  2019-05-23

5.  Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.

Authors:  Juha Puustinen; Ritva Lähteenmäki; Päivi Polo-Kantola; Paula Salo; Tero Vahlberg; Alan Lyles; Pertti J Neuvonen; Markku Partinen; Ismo Räihä; Sirkka-Liisa Kivelä
Journal:  Eur J Clin Pharmacol       Date:  2013-12-12       Impact factor: 2.953

6.  Phenobarbital withdrawal seizures may occur over several weeks before remitting: human data and hypothetical mechanism.

Authors:  Jean M Bidlack; Harold H Morris
Journal:  Seizure       Date:  2008-08-03       Impact factor: 3.184

Review 7.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

8.  Benzodiazepine prescribing patterns in a high-prescribing Scandinavian community.

Authors:  A Ekedahl; J Lidbeck; T Lithman; D Noreen; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 9.  Benzodiazepine dependence and its treatment with low dose flumazenil.

Authors:  Sean David Hood; Amanda Norman; Dana Adelle Hince; Jan Krzysztof Melichar; Gary Kenneth Hulse
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

Review 10.  Guidelines for the rational use of benzodiazepines. When and what to use.

Authors:  H Ashton
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.